Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Solek P et al. | 2018 | - | 50/60 Hz, magnetic field | - |
Sun C et al. | 2018 | intact cell/cell culture, mouse embryonic fibroblasts (wild type and <i>Atm</i>-deficient) | 50/60 Hz, magnetic field | 2 mT |
Wang Y et al. | 2019 | intact cell/cell culture, human ventricular cardiomyocytes cell line (AC16), animal, rat/Sprague Dawley, whole body | 50/60 Hz, magnetic field | 100 µT |
Koziorowska A et al. | 2017 | intact cell/cell culture, human neonatal fibroblast BJ | 50/60 Hz, magnetic field, low frequency, signals/pulses | 2.5 mT |
Gaafar RM et al. | 2018 | plant, broad Bean (<i>Vicia faba</i>) | 50/60 Hz, power transmission line, magnetic field, electric field | 720–4,051 µT |
Schimmelpfeng J et al. | 1993 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) | electric field, magnetic field, 50/60 Hz | 2 mT |
Cohen MM et al. | 1986 | intact cell/cell culture, human peripheral blood and 5 lymphoblastoid cell lines (normal - GM 1525, ataxia telangiectasia - GM 1525, xeroderma pigmentosum - D 7031, Bloom syndrome - GM 4408, Fanconi anemia - HSC 230) | electric field, magnetic field, 50/60 Hz | 0.1–0.2 mT |
Cohen MM et al. | 1986 | intact cell/cell culture, human peripheral blood lymphocytes | electric field, magnetic field, 50/60 Hz | 100–200 µT |
Goodman EM et al. | 1976 | intact cell/cell culture, slime mold microplasmodia (<i>Physarum polycephalum</i>, line M<sub>3</sub>C VI) | electric field, magnetic field, low frequency, 50/60 Hz | 200 µT |
Marron MT et al. | 1975 | intact cell/cell culture, slime mold microplasmodia and macroplasmodia (<i>Physarum polycephalum</i>) | electric field, magnetic field, low frequency, 50/60 Hz | 40–200 µT |
Cossarizza A et al. | 1993 | intact cell/cell culture, human peripheral blood mononuclear cells | electric field, magnetic field, signals/pulses, 50/60 Hz | 2.5 mT |
Denaro V et al. | 2011 | intact cell/cell culture | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.4 mT |
Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
Antonopoulos A et al. | 1995 | intact cell/cell culture, human peripheral blood | magnetic field, 50/60 Hz | 5 mT |
Rosenthal M et al. | 1989 | intact cell/cell culture, human peripheral blood | magnetic field, 50/60 Hz | 0.1–7.5 mT |
Cridland NA et al. | 1999 | intact cell/cell culture, HF-19 cells (human fetal lung fibroblasts) | magnetic field, 50/60 Hz | 20 µT–20 mT |
Lange S et al. | 2002 | intact cell/cell culture, human diploid amniotic fluid cells | magnetic field, 50/60 Hz | 1 mT |
Harris PA et al. | 2002 | intact cell/cell culture, HeLa S3 (human cervical carcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
Saalman E et al. | 1991 | intact cell/cell culture, V79 (Chinese hamster fibroblast cells) | magnetic field, 50/60 Hz | 30 µT |
Wolf FI et al. | 2005 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells); WI-38 (embryonic human lung fibroblasts); Rat-1 (rat fibroblasts) | magnetic field, 50/60 Hz | 500 µT–1 mT |
Sul AR et al. | 2006 | intact cell/cell culture, hFOB 1.19 (human fetal osteoblasts), T/G HA-VSMC (human aortic vascular smooth muscle cells), RPMI 7666 (human B lymphoblasts) and HCN-2 (human cortical neuronal cells) | magnetic field, 50/60 Hz | 2 mT |
Guo H et al. | 2004 | intact cell/cell culture, SNU cells (human gastric adenocarcinoma cell line) | magnetic field, 50/60 Hz | 97 mT |
Ruiz-Gomez MJ et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/wild type (WS8105-1C) and <i>rad52 hdf1</i> mutants (<i>rad52</i>, <i>hdf1</i>, <i>rad52 hdf1</i>; radiation sensitive 52, high affinity DNA binding factor 1) | magnetic field, 50/60 Hz | 2.45 mT |
Ma Q et al. | 2014 | intact cell/cell culture, embryonic neural stem cells (mouse/BALB/c) | magnetic field, 50/60 Hz | 0.5–2 mT |
Huang CY et al. | 2014 | intact cell/cell culture, human epidermal keratinocytes (derived from neonatal foreskin) and HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1.5 mT |
An GZ et al. | 2015 | intact cell/cell culture, BALB/3T3 cells (embryonal mouse fibroblasts) | magnetic field, 50/60 Hz | 2.3 mT |
Liu Y et al. | 2016 | intact cell/cell culture, GC-2 cells (murine spermatocyte-derived cell line) | magnetic field, 50/60 Hz | 1–3 mT |
Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 60 µT |
Yadamani S et al. | 2020 | - | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Schimmelpfeng J | 1997 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
Markkanen A et al. | 2001 | yeast (<i>Saccharomyces cerevisiae</i>/SEy2101a) | magnetic field, 50/60 Hz, co-exposure | 120 µT |
Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
Tian F et al. | 2002 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells (Ku80-proficient) und xrs5 cells (Ku80-defizient; radiation sensitive mutant isolated from CHO-K1 cells) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
Richard D et al. | 2002 | intact cell/cell culture, human diploid amniotic fluid cells | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 60 µT |
Markkanen A et al. | 2008 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 100–300 µT |
Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
Giorgi G et al. | 2014 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Jin H et al. | 2015 | intact cell/cell culture, L123 cells (human lung epithelial cells) | magnetic field, 50/60 Hz, co-exposure | 1–2 mT |
Martinez MA et al. | 2016 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Luukkonen J et al. | 2017 | intact cell/cell culture, human neuroblastoma cell line (SH-SY5Y) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Lange S et al. | 2004 | intact cell/cell culture, human amniotic fluid cells (AFC) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 1 mT |
Livingston GK et al. | 1991 | intact cell/cell culture, human peripheral blood lymphocytes and Chinese hamster ovary (CHO) cells | magnetic field, 50/60 Hz, electric current application | 0.22 mT |
Koziorowska A et al. | 2017 | intact cell/cell culture, pig anterior pituitary gland cells | magnetic field, 50/60 Hz, low frequency | 2–6 mT |
Xu A et al. | 2020 | - | magnetic field, 50/60 Hz, low frequency | - |
Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
Salinas-Asensio MM et al. | 2019 | - | magnetic field, 50/60 Hz, low frequency, signals/pulses, co-exposure, therapeutic/medical device | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.